Abstract
The aim of the present study is to investigate the potential anti-hepatocellular carcinoma (HCC) cell activity by 4SC-202, a novel class I HDAC inhibitor (HDACi). The associated signaling mechanisms were also analyzed. We showed that 4SC-202 treatment induced potent cytotoxic and proliferation-inhibitory activities against established HCC cell lines (HepG2, HepB3, SMMC-7721) and patient-derived primary HCC cells. Further, adding 4SC-202 in HCC cells activated mitochondrial apoptosis pathway, which was evidenced by mitochondrial permeability transition pore (mPTP) opening, cytochrome C cytosol release and caspase-3/-9 activation. Inhibition of this apoptosis pathway, by caspase-3/-9 inhibitors, mPTP blockers, or by shRNA-mediated knockdown of cyclophilin-D (Cyp-D, a key component of mPTP), significantly attenuated 4SC-202-induced HCC cell death and apoptosis. Reversely, over-expression of Cyp-D enhanced 4SC-202's sensitivity in HCC cells. Further studies showed that 4SC-202 induced apoptosis signal-regulating kinase 1 (ASK1) activation, causing it translocation to mitochondria and physical association with Cyp-D. This mitochondrial ASK1-Cyp-D complexation appeared required for mediating 4SC-202-induced apoptosis activation. ASK1...Continue Reading
References
Mar 21, 2002·Nature Reviews. Cancer·P MarksW K Kelly
May 23, 2002·Biochimie·Andrew P HalestrapSamantha J Clarke
Jul 4, 2002·The Journal of Biological Chemistry·Samantha J ClarkeAndrew P Halestrap
Jan 24, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Josep M Llovet, Jordi Bruix
Mar 21, 2006·Biochemical Society Transactions·A P Halestrap
Sep 22, 2007·Annual Review of Pharmacology and Toxicology·Kohsuke TakedaHidenori Ichijo
Nov 16, 2007·Oncology·Tatsuya RikimaruYoshihiko Maehara
Oct 1, 2008·Cancer Letters·Olaf WittIna Oehme
Dec 10, 2008·Nature Reviews. Drug Discovery·Ernest C BordenJohn Crowley
Dec 10, 2008·Nature Reviews. Drug Discovery·David Huang, Kimihisa Ichikawa
Dec 24, 2008·Cancer Letters·Wilko Weichert
Jul 6, 2011·Journal of Ethnopharmacology·Jing LiZhengfeng Yin
Oct 22, 2011·Nature Reviews. Molecular Cell Biology·Andrew Oberst, Douglas R Green
Dec 2, 2011·PloS One·Ji Heon NohSuk Woo Nam
Mar 21, 2012·Cell Proliferation·X WenY-Q Wei
Jun 26, 2012·Cell·Angelina V VasevaUte M Moll
Mar 19, 2013·Cancer Letters·Ji Heon NohSuk Woo Nam
Mar 30, 2013·Circulation Journal : Official Journal of the Japanese Circulation Society·John W Elrod, Jeffery D Molkentin
Nov 16, 2013·Nature Reviews. Drug Discovery·Jonas W HøjfeldtKristian Helin
Mar 13, 2014·Journal of Cellular Physiology·Yun-Fang ZhenXiao-Dong Wang
Apr 17, 2014·Biochemical and Biophysical Research Communications·Ying QiuHui Sun
Jul 27, 2014·Biochemical and Biophysical Research Communications·Koulong ZhengHuihe Lu
Aug 19, 2014·Nature Reviews. Drug Discovery·Katrina J Falkenberg, Ricky W Johnstone
Apr 15, 2015·Cancer Biology & Therapy·Yun-Rong ZhuYun-Qing Zhang
Jun 10, 2015·Current Opinion in Pharmacology·Tamara MaesCarlos Buesa
Citations
May 5, 2016·Biochemical and Biophysical Research Communications·Meili FuHaiyan Liu
Jun 18, 2016·Biochemical and Biophysical Research Communications·Xingang PengHaiyan Liu
Jul 9, 2016·Biochemical and Biophysical Research Communications·Yongsheng JiangBaoyou Sun
Sep 17, 2016·Cancer Biology & Therapy·Alexander BeckRoland Kappler
Feb 22, 2017·Protein Science : a Publication of the Protein Society·Ken InuiMonika M Golas
Apr 27, 2017·PloS One·Xi YangYong-Qing Xu
Apr 27, 2019·Cancer Medicine·Yuan HeJuan Xia
Oct 31, 2019·Clinical and Experimental Pharmacology & Physiology·Yomna S Mo'menMohamed A Kandeil
Dec 24, 2019·Expert Opinion on Investigational Drugs·Daren R UreRobert T Foster
Dec 31, 2016·Oncotarget·Mao-Chuan ZhenZhen-Yu Yin
Dec 17, 2017·Oncotarget·Mingming ZhangXiaoping Zou
Nov 23, 2017·Oncotarget·Jinyu ZhengDe-Rong Tang
May 8, 2020·Molecular Medicine Reports·Meixi LiuXiao Yuan
Aug 18, 2020·Clinical Science·Tao QiuXiaoxiong Ma
Mar 20, 2019·Journal of Hematology & Oncology·Marion WobserRoland Houben
Jun 3, 2016·Targeted Oncology·Maria PinkerneilGünter Niegisch
Jun 28, 2019·Frontiers in Pharmacology·Srinivas Patnaik, Anupriya
Oct 21, 2017·Journal of Experimental & Clinical Cancer Research : CR·Xian QinQuan-Yan Liu
Mar 27, 2020·Cancers·Mariah M HoffmanShanta M Messerli
Dec 2, 2020·Cell Death & Disease·Ling ChenQian Chu
Nov 6, 2020·OncoTargets and Therapy·Yuan HeJuan Xia
Sep 22, 2020·Biochemical Pharmacology·Yuan GaoTian Xie
Mar 28, 2021·Oral Diseases·Xi YangXueyi Liang
May 7, 2021·European Journal of Medicinal Chemistry·Ying-Chao DuanYuan-Yuan Guan
Jun 10, 2021·European Journal of Medicinal Chemistry·Ying-Chao DuanYuan-Yuan Guan
Aug 28, 2021·Cancers·Haydee M TorresJianning Tao
Sep 27, 2020·Cell Death & Disease·An-Cheng QinXing-Sheng Lu
Apr 24, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Jiali YangGuanghui Wang